Search academic texts

Registration Number

0215U003391, 0110U005967 , R & D reports

Title

RECOMBINANT BLOOD COAGULATION SYSTEM PROTEINS GENERATION AND THEIR CHARACTERISTICS INVESTIGATION FOR DIC-SYNDROME DIAGNOSTICS AND TREATMENT.

Head

Komisarenko Serhiy, Доктор біологічних наук

Registration Date

28-01-2015

Organization

A.V.Palladin Institute of Biochemistry of National Academy of Sciences

Description

The aim of this project was the generation of monoclonal antibodies and recombinant scFv-antibodies against human protein C. These antibodies should be suitable for generation of immunochemical methods for human plasma protein C detection in case of disseminated intravascular coagulation syndrome (DIC-syndrome) and trombofilia. Also during this work stable cell lines for recombinant protein C generation should be obtained. This protein C could be used for DIC-syndrom therapy. In this study modern chemical, biochemical, bioinformatical, immunochemical and molecular biology methods were used. During the project highly immunogenic unique aminoacid sequences of protein C molecule were determined, appropriate peptide synthesized and with carrier proteins conjugated. Splenocytes of mice immunized with KLH-Pro144-Leu155 were hybridized with myeloma Х-63Ag8 cells.Stable clone producer of monoclonal antibodies against Pro144-Leu155 fragment of human ptotein C was obtained. It was shown that monoclonal antibodies ІV-6А which have been produced by this clone specific bind human protein C and could be used for design immunoenzymes test-systhems for protein C detection in blood plasma. Also it was shown that monoclonal antibodies ІV-6А could be used for protein C elution and purification by affinity chromatography. Immune libraries of immunized with protein C and Pro144-Leu155 protein C region-KLH conjugate mice genes were generated. The library was screened against Pro144-Leu155 protein C region-KLH and -BSA conjugates and one scFv producer clone was isolated. Recombinant anti-protein C scFv producing clones were selected. The best clone DNA sequence was subcloned into pET-22b expression vector and recombinant anti-protein C scFv producer based on E. coli Rosetta was obtained. It was shown that obtained 9Е scFv antibodies could specific bind protein C in immunoensyme analysis and immunoblotting and could be used for design of immunochemical methods for protein C detection. Two genetic construction for protein C expression in eukaryotic cells based on pEGFP plasmid were design. They contain CMV or EF-1alfa promoter. 3Т3, HEK293 and CHO cell lines were transfected with these plasmids. Then protein C expression in these cells were investigated. One effective recombinant protein C producing clone was selected from transected with pEGFP-N1-protein C HEK293 cells. Recombinant scFv antibodies 9E and monoclonal antibodies ІV-6А against protein C would be used for design of immunochemical test systhems for protein C detection in human blood plasma, which is important for trombofilia and DIC-syndrome diagnostics as well as affinic sorbents for protein C elution and purification. Recombinant protein C producer could be used for obtaining of protein C as antithrombotic and aceptic agent for DIC-syndrome and other human deseases treatment.

Product Description

popup.authors

Богатирьова О. А.
Колеснікова І. М.
Костюченко О. П.
Литвинова Л. М.
Луговська Н. Е.
Луговськой Е. В.
Макогоненко Є. М.
Олійник О. С.
Паливода К. О.
Пидюра М.О.